Simon S. Jones
72 works · 5,300 citations · h-index 25
Top works
- Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins
- Isolation and characterization of genomic and cDNA clones of human erythropoietin
- Specific amino acid substitutions in bacterioopsin: Replacement of a restriction fragment in the structural gene by synthetic DNA fragments containing altered codons
- Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists
- Synthesis of the 3'-terminal decaribonucleoside nonaphosphate of yeast alanine transfer ribonucleic acid
- A Novel Cytosolic Calcium-independent Phospholipase A2 Contains Eight Ankyrin Motifs
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells1
- Activation of Ha-ras p21 by substitution, deletion, and insertion mutations.
- The protection of uracil and guanine residues in oligonucleotide synthesis
- Identity between the Ca2+-independent Phospholipase A2 Enzymes from P388D1 Macrophages and Chinese Hamster Ovary Cells
- Chemical synthesis of 5'-O-triphosphoryladenylyl-(2' .fwdarw. 5')-adenylyl-(2' .fwdarw. 5')-adenosine (2-5A)
- Migration of t-butyldimethylsilyl protecting groups
- Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma
- Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
- Activation of Ha- ras p21 by Substitution, Deletion, and Insertion Mutations
- The 2-(methylthiomethoxy)ethoxycarbonyl [mtmec] protecting group
- Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
- Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non–Small Cell Lung Cancer
- Molecular cloning of the cDNA encoding a receptor tyrosine kinase‐related molecule with a catalytic region homologous to c‐ met